Advertisement
Advertisement

PASG

PASG logo

Passage Bio, Inc. Common Stock

4.21
USD
Sponsored
+0.13
+3.19%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

4.34

+0.13
+3.09%

Passage Bio, Inc. Common Stock Profile

About

Passage Bio Inc. is a genetic medicines company. It is focused on developing transformative therapies for rare, monogenic central nervous system diseases. The company's principal product includes GM1 gangliosidosis, frontotemporal dementia and Krabbe disease which is in clinical stage. Passage Bio Inc. is based in Philadelphia, United States.

Info & Links

CEO

William Chou

Headquarters

ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR
PHILADELPHIA, PA 19103, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.passagebio.com

Auditor

KPMG LLP

Share holders

26

Employees

24

Passage Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

13.92M

Enterprise Value

-32.38M

Enterprise Value/EBITDA(ttm)

0.67

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.90

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-135.04%

Return on Invested Capital(ttm)

-151.64%

Return on Assets(ttm)

-60.37%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-48.44M

Net Income Available to Common(ttm)

-45.52M

Diluted EPS(ttm)

-14.48

Share Statistics

Beta (5Y Monthly)

1.77

52-Week Change

-39.27%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

3.21M

Dividend Yield

0.00%

Float4

3.05M

% Held by Insiders

5.00%

% Held by Institutions

53.48%

Balance Sheet

Total Cash(mrq)

46.30M

Total Cash Per Share(mrq)

14.43

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.07%

Quick Ratio(mrq)

2.07%

Book Value Per Share(mrq)

5.89

Cash Flow

Operating Cash Flow Per Share(ytd)

-9.93

Free Cash Flow(ytd)

-30.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement